Cytosorbents Corporation logo
Cytosorbents Corporation CTSO
$ 0.91 2.75%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Cytosorbents Corporation Financial Ratios 2011-2024 | CTSO

Annual Financial Ratios Cytosorbents Corporation

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

-4.8 -6.6 -52.0 -8.3 -13.2 -24.8 -11.8 -11.8 -12.4 -14.1 -5.7 -4.4

P/S

16.8 15.0 34.1 6.4 10.1 13.9 14.8 19.9 28.0 27.3 15.5 661.8

EPS

-0.0 -0.2 -0.2 -0.6 -0.6 -0.3 -0.5 -0.3 -1.3 -0.0 -0.0 -0.1

EV (Enterprise Value)

163 M 136 M 347 M 172 M 220 M 206 M 146 M 93.3 M 116 M 82.2 M 34 M 24.5 M

EBITDA per Share

-0.13 -0.2 -0.05 -0.57 -0.495 -0.349 -0.445 -0.369 -0.502 -0.492 -0.433 -0.686

EV/EBITDA

-4.8 -34.8 -8.9 -14.1 -21.0 -12.4 -9.8 -15.5 -14.1 -5.8 -5.3

PEG

-0.1 -0.13 7.39 1.16 0.18 -0.78 0.28 -0.16 0.17 6.92 -0.14 1.45

P/B

4.4 2.6 5.1 46.8 13.4 20.4 -297.7 11.6 29.1 -4.6 -1.8 75.0

P/CF

-5.6 -11.5 -72.5 -8.8 -18.4 -25.8 -19.3 -9.9 -16.4 -17.8 -5.7 -6.2

ROE %

-92.76 -39.24 -9.89 -563.65 -101.63 -82.44 2518.28 -99.04 -235.21 32.79 31.51 -1721.93

ROA %

-51.89 -27.43 -8.71 -70.36 -52.56 -35.10 -123.16 -72.25 -110.07 -115.62 -109.71 -258.26

ROCE %

-17.97 -15.28 -3.33 -108.76 -59.46 -60.55 -318.85 -113.31 -183.66 -480.55 -276.46 -746.19

Current Ratio

2.3 3.3 8.4 2.1 4.3 2.6 1.3 3.2 1.7 1.1 1.4 1.1

DSO

198.0 163.9 146.9 65.4 64.0 53.1 54.9 49.4 72.5 68.3 14.1 365.0

DIO

107.6 122.9 79.1 104.8 40.6 52.6 77.0 196.4 92.0 46.9 780.0 13377.8

DPO

58.3 76.7 64.0 132.3 95.8 103.6 122.8 112.9 119.4 150.2 915.3 20955.2

Operating Cycle

305.6 286.8 226.0 170.1 104.6 105.8 131.9 245.9 164.5 115.1 794.1 13742.8

Cash Conversion Cycle

247.3 210.1 162.0 37.9 8.8 2.1 9.1 132.9 45.0 -35.0 -121.2 -7212.4

All numbers in USD currency

Quarterly Financial Ratios Cytosorbents Corporation

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

-0.04 -0.08 -0.12 - -0.21 -0.14 -0.17 - -0.28 -0.25 -0.21 -0.25 -0.15 -0.11 -0.1 - -0.02 -0.08 -0.1 -0.13 -0.21 -0.11 -0.15 -0.17 -0.1 -0.19 -0.1 -0.12 -0.07 -0.07 -0.06 -0.19 -0.09 -0.12 -0.07 -0.08 -0.11 0.06 -0.19 -0.84 -0.22 -0.27 -0.2 - -0.01 -0.01 -0.01 - -0.01 -0.01 -0.01 - -0.01 -0.01 -0.01

EBITDA per Share

- - -0.08 - - - -0.17 - -0.19 -0.19 -0.17 -0.22 -0.11 -0.11 -0.06 -0.06 -0.04 -0.08 -0.07 -0.17 -0.16 -0.1 -0.13 -0.18 -0.08 -0.13 -0.1 -0.13 -0.07 -0.08 -0.06 -0.18 -0.08 -0.1 -0.08 -0.09 -0.08 -0.09 -0.11 -0.12 -0.11 -0.11 -0.11 - - -0.01 -0.01 - - -0.01 -0.01 - -0.01 -0.01 -0.01

ROE %

-125.96 -157.67 -158.45 -100.50 -131.67 -113.18 -110.52 -70.22 -85.10 -63.00 -46.41 -35.63 -21.61 -13.60 -10.93 -9.89 -124.58 -324.96 -425.12 -563.65 -480.01 -296.32 -226.91 -101.63 -100.39 -102.66 -85.19 -82.44 -418.59 -562.18 88.62 490.81 831.94 960.87 344.43 -100.35 -225.73 -228.86 -293.10 -260.25 -102.42 -57.85 -1.16 28.10 33.71 32.55 31.64 26.89 -516.21 -1064.92 -1495.23 -1345.94 -543.10 -421.30 -381.53

ROA %

-45.47 -59.91 -63.89 -43.81 -63.40 -63.67 -62.70 -41.13 -51.53 -27.90 -32.67 -26.66 -17.02 -11.21 -9.64 -8.71 -22.38 -46.59 -56.36 -70.36 -71.73 -55.38 -59.45 -50.33 -47.59 -47.32 -37.50 -35.10 -72.66 -86.70 -110.51 -123.13 -94.99 -97.72 -53.97 -76.94 -178.35 -170.75 -205.38 -174.98 -74.94 -81.10 -94.18 -99.09 -118.61 -114.29 -110.67 -93.61 -175.06 -236.99 -268.82 -201.87 -81.46 -63.19 -57.22

ROCE %

- - - - -23.04 -46.08 -63.65 -54.67 -69.95 -54.56 -43.61 -33.25 -21.29 -16.11 -13.65 -13.09 -168.67 -330.84 -432.87 -555.12 -429.19 -280.56 -199.09 -92.03 -96.13 -101.06 -99.04 -95.91 -400.55 -539.93 49.63 505.67 824.91 959.04 365.06 -108.83 -127.98 -139.23 -146.50 -142.60 -94.79 -51.19 -6.93 26.00 31.17 30.17 29.00 23.04 -183.10 -394.41 -590.48 -583.31 -206.14 -187.38 -189.79

Current Ratio

1.4 1.5 1.7 1.8 1.6 1.9 2.0 2.3 2.7 - 3.0 3.3 3.9 4.1 8.6 8.4 8.4 8.4 8.4 1.1 1.1 1.1 1.1 2.0 2.0 2.0 2.0 1.7 1.7 1.7 1.7 1.2 1.2 0.9 0.9 3.7 3.7 3.7 - - - - - 1.3 1.3 1.9 4.1 1.6 1.6 1.6 1.6 1.2 1.2 1.2 1.2

DSO

70.2 67.3 59.8 - 68.4 60.8 54.0 - 27.9 24.6 47.8 41.3 51.4 40.9 43.8 39.4 44.6 48.1 50.4 54.9 66.9 65.4 73.9 59.2 62.6 62.5 57.0 43.3 52.6 56.4 53.3 42.4 54.2 58.9 52.5 33.6 39.0 55.5 94.1 72.1 35.0 51.2 54.6 - 46.9 141.8 62.0 - 7.8 56.9 79.8 - - - -

DIO

84.0 108.4 105.3 - 71.5 50.6 59.2 - 36.0 70.0 204.6 - 152.2 114.4 95.9 - 84.4 75.1 91.6 - 113.7 105.2 77.3 - 37.0 42.6 47.4 - 47.9 49.0 - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

59.8 73.3 88.0 - 89.4 78.2 53.1 - 23.8 62.0 152.9 - 102.3 64.7 58.2 - 57.9 51.5 74.1 - 109.7 101.4 92.5 - 66.0 75.9 79.5 - 74.9 76.6 - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

154.2 175.6 165.0 - 139.9 111.4 113.3 - 63.9 94.5 252.3 41.3 203.6 155.3 139.7 39.4 129.1 123.1 142.0 54.9 180.6 170.6 151.2 59.2 99.7 105.1 104.4 43.3 100.5 105.4 53.3 42.4 54.2 58.9 52.5 33.6 39.0 55.5 94.1 72.1 35.0 51.2 54.6 - 46.9 141.8 62.0 - 7.8 56.9 79.8 - - - -

Cash Conversion Cycle

94.4 102.4 77.0 - 50.5 33.2 60.2 - 40.0 32.5 99.5 41.3 101.3 90.6 81.4 39.4 71.1 71.6 67.9 54.9 70.9 69.1 58.7 59.2 33.6 29.2 24.9 43.3 25.6 28.8 53.3 42.4 54.2 58.9 52.5 33.6 39.0 55.5 94.1 72.1 35.0 51.2 54.6 - 46.9 141.8 62.0 - 7.8 56.9 79.8 - - - -

All numbers in USD currency